cas 90111-23-2|| where to buy 2-(Thiophen-2-yl)cyclopropane-1-carboxylic acid

Nombre del producto:2-(Thiophen-2-yl)cyclopropane-1-carboxylic acid

IUPAC Name:2-(thiophen-2-yl)cyclopropane-1-carboxylic acid

Unidad de embalaje	Stock disponible	Precio($)
CM199441-100mg	in stock	ŪŞȖ
CM199441-250mg	in stock	Ūƃƥ
CM199441-1g	in stock	ǫƥǑ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 90111-23-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :90111-23-2; Fórmula molecular:C8H8O2S; Punto de fusión:-; Código de sonrisas:O=C(C1C(C2=CC=CS2)C1)O; Densidad:

: Número de catálogo:CM199441; Peso molecular:168.21; Punto de ebullición:; Nº Mdl:MFCD11186844; Almacenamiento:

: Thiophenes; Thiophene is a five-membered heterocyclic compound containing a sulfur heteroatom with the molecular formula C4H4S. Thiophene is aromatic and is very similar to benzene; electrophilic substitution reaction is easier than benzene, and it is mainly substituted at the 2-position. Thiophene ring system has certain stability to oxidant.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.